For instance, in breast carcinoma, NCoA3 has been suggested as a major coactivator of ERRα with binding to the ERREs of ERRα target genes and transcriptional regulation of transfected ERRα-responsive promoters [34]. This evidence concerns the gene ESRRA and breast carcinoma.